Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients. Expert Opinion on Drug Safety 22:1, pages 25-41.
Read now
Read now
Parichat Mhusakunchai & Leelawadee Techasatian. (2021) An Association of Pediatric Psoriasis with Metabolic Syndrome in Thai Children: 20 Years Retrospective Study. Psoriasis: Targets and Therapy 11, pages 75-82.
Read now
Read now
Florence Libon, Eve Lebas, Virginie De Schaetzen, Murielle Sabatiello, Sofie De Schepper & Arjen F. Nikkels. (2021) Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients. Expert Review of Clinical Immunology 17:9, pages 947-955.
Read now
Read now
A. Zangrilli, M. Bavetta & L. Bianchi. (2020) Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation. Expert Opinion on Drug Safety 19:4, pages 433-438.
Read now
Read now
Articles from other publishers (17)
Rahul Masson, Elaine Ma, Neha Parvathala, Terri Shih, Swetha Atluri, Marcia Hogeling, Meagan Hughes, Christopher J. Sayed, Vivian Y. Shi & Jennifer L. Hsiao. (2023) Efficacy of medical treatments for pediatric hidradenitis suppurativa: A systematic review. Pediatric Dermatology.
Crossref
Crossref
Tithi Roy, Samuel T. Boateng, Mohammad B. Uddin, Sergette Banang-Mbeumi, Rajesh K. Yadav, Chelsea R. Bock, Joy T. Folahan, Xavier Siwe-Noundou, Anthony L. Walker, Judy A. King, Claudia Buerger, Shile Huang & Jean Christopher Chamcheu. (2023) The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds. Cells 12:12, pages 1671.
Crossref
Crossref
Yu-Xin Zheng, Li-Ran Ye, Bing-Xi Yan, Si-Qi Chen, Sui-Qing Cai & Xiao-Yong Man. (2022) Biologics for psoriasis patients under 18 years of age: Real-world evidence from the Chinese psoriasis real world evidence research group. Frontiers in Medicine 9.
Crossref
Crossref
Muskaan Sachdeva, Patrick Kim, Asfandyar Mufti, Khalad Maliyar, Cathryn Sibbald & Afsaneh Alavi. (2021) Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review. Journal of Cutaneous Medicine and Surgery 26:2, pages 176-180.
Crossref
Crossref
Marieke M.B. Seyger, Matthias Augustin, Michael Sticherling, Teresa Bachhuber, Juanzhi Fang, James Hetherington, James Lucas, Sophie Meakin, Craig Richardson & Amy S. Paller. (2022) Physician-reported Clinical Unmet Needs, Burden and Treatment Patterns of Paediatric Psoriasis Patients: A US and EU Real-world Evidence Study. Acta Dermato-Venereologica 102, pages adv00660.
Crossref
Crossref
Rosa Rodríguez‐Mauriz, Carlos Seguí Solanes, Isabel Masiques Mas & Nuria Rudi Sola. (2021) Ustekinumab Dose Intensification in Paediatric Crohn's Disease. Journal of Paediatrics and Child Health 57:7, pages 1148-1148.
Crossref
Crossref
Isa Vieira, João José Sousa & Carla Vitorino. (2021) Paediatric Medicines – Regulatory Drivers, Restraints, Opportunities and Challenges. Journal of Pharmaceutical Sciences 110:4, pages 1545-1556.
Crossref
Crossref
BhumeshKumar Katakam, Malathi Munisamy, TNarayana Rao, MinuJose Chiramel, Maitreyee Panda, Sandeep Gupta, PS S Ranugha & KA Seetharam. (2021) Recommendations for management of childhood psoriasis. Indian Dermatology Online Journal 12:7, pages 71.
Crossref
Crossref
Starling Tolliver, Amber N. Pepper, Salma Pothiawala & Nanette B. Silverberg. 2021. Advances in Psoriasis. Advances in Psoriasis
311
342
.
Nikolay N. Murashkin, Alexander I. Materikin, Eduard T. Ambarchian, Roman V. Epishev, Leonid A. Opryatin, Roman A. Ivanov, Daria S. Kukoleva, Daria G. Kuptsova & Marina U. Pomazanova. (2020) Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood. Current Pediatrics 19:6, pages 444-451.
Crossref
Crossref
Nida Aslam, Hajra Saleem, Salikh Murtazaliev, Sohail J Quazi & Safeera Khan. (2020) FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review. Cureus.
Crossref
Crossref
Andreas Pinter, Nicole Mielke, Bartosz Malisiewicz, Roland Kaufmann & Anke König. (2020) Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey. Dermatology and Therapy 10:4, pages 671-680.
Crossref
Crossref
Inge M. G. J. Bronckers, Amy S. Paller, Dennis P. West, Irene Lara-Corrales, Megha M. Tollefson, Wynnis L. Tom, Marcia HogelingLeah Belazarian, Claus Zachariae, Emmanuel Mahé, Elaine Siegfried, Ulrike Blume-Peytavi, Zsuzsanna Szalai, Ruth Ann Vleugels, Kristen Holland, Ruth Murphy, Lluís Puig, Kelly M. Cordoro, Jo Lambert, Alex Alexopoulos, Ulrich Mrowietz, Wietske Kievit & Marieke M. B. Seyger. (2020) A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents. JAMA Dermatology 156:4, pages 384.
Crossref
Crossref
Perla Lansang, James N. Bergman, Loretta Fiorillo, Marissa Joseph, Irene Lara-Corrales, Danielle Marcoux, Catherine McCuaig, Elena Pope, Vimal H. Prajapati, Sue Z.J. Li & Ian Landells. (2020) Management of pediatric plaque psoriasis using biologics. Journal of the American Academy of Dermatology 82:1, pages 213-221.
Crossref
Crossref
D. Thaçi, K. Papp, D. Marcoux, L. Weibel, A. Pinter, P.‐D. Ghislain, I. Landells, P.H. Hoeger, K. Unnebrink, M.M.B. Seyger, D.A. WilliamsS. Rubant & S. Philipp. (2019)
Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase
III
study
. British Journal of Dermatology 181:6, pages 1177-1189.
Crossref
Crossref
C. Phan, A. Beauchet, A.‐C. Burztejn, M. Severino‐Freire, S. Barbarot, C. Girard, A. Lasek, Z. Reguiai, S. Hadj‐Rabia, C. Abasq, E. Brenaut, C. Droitcourt, M. Perrussel, S. Mallet, A. Phan, J.‐P. Lacour, A. Khemis, E. Bourrat, G. Chaby, R. Deborde, P. Plantin, A. Maruani, M. Piram, F. Maccari, A.‐C. Fougerousse, I. Kupfer‐Bessaguet, X. Balguérie, H. Barthelemy, L. Martin, N. Quiles‐Tsimaratos, L. Mery‐Brossard, V. Pallure, D. Lons‐Danic, D. Bouilly‐Auvray, M. Beylot‐Barry, E. Puzenat, F. Aubin & E. Mahé. (2019) Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis. Journal of the European Academy of Dermatology and Venereology 33:10, pages 1984-1992.
Crossref
Crossref
Tal Engel, Diana E. Yung, Christopher Ma, Benjamin Pariente, Pauline WIls, Rami Eliakim, Bella Ungar, Shomron Ben-Horin & Uri Kopylov. (2019) Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence. Digestive and Liver Disease 51:9, pages 1232-1240.
Crossref
Crossref